{"DataElement":{"publicId":"3191494","version":"1","preferredName":"Antiestrogen Therapy Administered Indicator","preferredDefinition":"an indicator related to drug treatment to block the action of the female hormone estrogen being given.","longName":"3191489v1.0:3191491v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3191489","version":"1","preferredName":"Antiestrogen Therapy Administered","preferredDefinition":"information related to drug treatment to block the action of the female hormone estrogen being given.","longName":"3191487v1.0:2233610v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3191487","version":"1","preferredName":"Antiestrogen Therapy","preferredDefinition":" Drug treatment to block the action of the female hormone estrogen.","longName":"C15757","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiestrogen Therapy","conceptCode":"C15757","definition":"Drug treatment to block the action of the female hormone estrogen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DC43-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DC50-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3191491","version":"1","preferredName":"Antiestrogen Therapy Indicator","preferredDefinition":"information related to indicator for a drug treatment to block the action of the female hormone estrogen.","longName":"3191491v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes, other","valueDescription":"Yes, other","ValueMeaning":{"publicId":"2619990","version":"1","preferredName":"Yes, other","longName":"2619990","preferredDefinition":"Yes, other","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2CC01FF9-2F52-74FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C05A576-DC93-5144-E040-BB89AD432C39","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","deletedIndicator":"No"},{"value":"Yes, Aromatase Inhibitor","valueDescription":"Yes, Aromatase Inhibitor","ValueMeaning":{"publicId":"3191492","version":"1","preferredName":"Yes, Aromatase Inhibitor","longName":"3191492","preferredDefinition":"Yes, Aromatase Inhibitor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DC9D-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C05A576-DCB6-5144-E040-BB89AD432C39","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","deletedIndicator":"No"},{"value":"Yes, Tamoxifen","valueDescription":"Yes, Tamoxifen","ValueMeaning":{"publicId":"3191493","version":"1","preferredName":"Yes, Tamoxifen","longName":"3191493","preferredDefinition":"Yes, Tamoxifen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DCC0-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C05A576-DCD9-5144-E040-BB89AD432C39","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","deletedIndicator":"No"},{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C05A576-DCE3-5144-E040-BB89AD432C39","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3191490","version":"1","preferredName":"Antiestrogen Therapy Indicator","preferredDefinition":" Drug treatment to block the action of the female hormone estrogen.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C15757:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiestrogen Therapy","conceptCode":"C15757","definition":"Drug treatment to block the action of the female hormone estrogen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DC6C-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"ONEDATA","dateModified":"2011-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C05A576-DC7D-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"REEVESD","dateModified":"2014-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"}]}],"AlternateNames":[{"name":"3191489v1.0:3191491v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text2","type":"Alternate Question Text","description":"Did the patient receive anti-endocrine therapy post protocol RT","url":null,"context":"CTEP"},{"name":"Did the patient receive anti","type":"Preferred Question Text","description":"Did the patient receive anti endocrine therapy during protocol RT","url":null,"context":"CTEP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9C05A576-DCED-5144-E040-BB89AD432C39","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-02-11","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}